Trial intelligence / Profile preview

Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol

NCT01713556Phase 2Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Nov 2012
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Centre hospitalier universitaire de Toulouse. Started Nov 2012; status: completed.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01713556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01713556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call